IL-1受体阻断在系统性硬化症小鼠模型中使炎症向Th2偏移
该研究在Fra-2转基因系统性硬化症小鼠模型中评估IL-1α和IL-1β在肺血管与间质重构中的作用。给予IL-1受体拮抗剂阿那白滞素8周后,小鼠肺纤维化和限制性通气功能障碍加重,Th2炎症增强,替代活化促纤维化巨噬细胞增多。提示阻断IL-1信号可能通过Th2偏移加重特定亚组患者的肺纤维化。
要点
- IL-1α和IL-1β在系统性硬化症患者和Fra-2转基因小鼠肺中表达增加。
- 阻断IL-1信号加重Fra-2小鼠肺纤维化和限制性通气障碍。
- IL-1阻断增强Th2炎症并增加替代活化促纤维化巨噬细胞。
核心结论
- 阻断IL-1信号可能通过Th2免疫偏移和形成替代活化促纤维化巨噬细胞,加重特定患者亚组的肺纤维化。
研究设计与样本
- 研究使用Fra-2转基因系统性硬化症小鼠模型,给予IL-1受体拮抗剂阿那白滞素25 mg·kg-1·day-1治疗8周,并体外研究IL-1对肺动脉平滑肌细胞和肺实质成纤维细胞的直接作用。
主要发现
- Fra-2转基因小鼠肺内胶原沉积增加、限制性通气功能障碍、血管肌化增强并伴肺动脉高压。
- IL-1α和IL-1β在Fra-2转基因小鼠和系统性硬化症患者肺中免疫反应性增加。
- IL-1刺激通过不同信号通路减少肺动脉平滑肌细胞和肺实质成纤维细胞的胶原表达。
- 阻断IL-1信号加重Fra-2转基因小鼠肺纤维化和限制性通气障碍,增强Th2炎症,增加替代活化促纤维化巨噬细胞数量。
临床怎么用
- 在临床研究IL-1阻断治疗系统性硬化症时,需警惕特定患者亚组肺纤维化加重的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The interleukin (IL)-1 family of cytokines is strongly associated with systemic sclerosis (SSc) and pulmonary involvement, but the molecular mechanisms are poorly understood. The aim of this study was to assess the role of IL-1α and IL-1β in pulmonary vascular and interstitial remodelling in a mouse model of SSc.IL-1α and IL-1β were localised in lungs of SSc patients and in the fos-related antigen-2 (Fra-2) transgenic (TG) mouse model of SSc. Lung function, haemodynamic parameters and pulmonary inflammation were measured in Fra-2 TG mice with or without 8 weeks of treatment with the IL-1 receptor antagonist anakinra (25 mg·kg-1·day-1). Direct effects of IL-1 on pulmonary arterial smooth muscle cells (PASMCs) and parenchymal fibroblasts were investigated in vitroFra-2 TG mice exhibited increased collagen deposition in the lung, restrictive lung function and enhanced muscularisation of the vasculature with concomitant pulmonary hypertension reminiscent of the changes in SSc patients. Immunoreactivity of IL-1α and IL-1β was increased in Fra-2 TG mice and in patients with SSc. IL-1 stimulation reduced collagen expression in PASMCs and parenchymal fibroblasts via distinct signalling pathways. Blocking IL-1 signalling in Fra-2 TG worsened pulmonary fibrosis and restriction, enhanced T-helper cell type 2 (Th2) inflammation, and increased the number of pro-fibrotic, alternatively activated macrophages.Our data suggest that blocking IL-1 signalling as currently investigated in several clinical studies might aggravate pulmonary fibrosis in specific patient subsets due to Th2 skewing of immune responses and formation of alternatively activated pro-fibrogenic macrophages.
引用
- Birnhuber A, Crnkovic S, Biasin V, et al. IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosis. Eur Respir J. 2019. PMID: 31320452. doi:10.1183/13993003.00154-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。